SKScott Koerber

Scott Koerber

*This is an algorithmically generated author record based on publicly available information.

Scott Koerber has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Incidence and Outcomes of Early Pacemaker Implantation for Sinus Node Dysfunction Following Atrial Fibrillation Ablation

    by Jiaqi Mi, Aashish Katapadi, Eli Herink, Douglas Darden, Naga Venkata K. Pothineni, Peter Park, Scott Koerber, Rakesh Gopinathannair, Rangarao Tummala, Sanghamitra Mohanty, et al.

    Introduction: Sinus node dysfunction (SND) may be observed following atrial fibrillation ablation (AFA), leading to urgent pacemaker (PPM) implantation. However, the incidence of PPM implantation and the long‐term outcomes are not well known. Objective: To assess the incidence and outcomes of PPM implantation for SND immediately after AFA and assess the long‐term requirement for pacing. Methods: We conducted a multi‐center, retrospective study of patients who underwent AFA from 2018 to 2024 and received PPM for SND during the same hospitalization. We assessed the patient and procedural characteristics, post‐PPM complications, and atrial pacing percentage (AP%) at 30 and 90 days. Results: Of the 8772 patients who underwent AFA, 178 patients (2.0%) received PPM implantation for SND during the same admission. The mean age was 78.6 ± 6.0 years; 48.3% were female, and 51.9% had non‐paroxysmal atrial fibrillation; 14.6% required temporary pacing. PPM implantation was associated with complications, including pocket hematoma (10.7%) and lead malfunction (1.2%). One patient required PPM explantation for pocket erosion following pocket hematoma. At 30 days, 33.1% of patients had AP > 50% with a mean AP% of 34.1 ± 39.2%. At 90 days, 31.5% patients had AP > 50% with a mean AP% of 33.7 ± 39.0%, and 6.7% were PPM‐dependent. Conclusions: While the incidence of PPM implantation for Sinus node dysfunction immediately following atrial fibrillation ablation is low, it is associated with an increased risk of complications, especially pocket hematoma. The need for atrial pacing decreased during follow‐up. Hence, extending the monitoring period must be considered before PPM implantation.

  • Outcomes of hybrid surgical ablation and concomitant left atrial appendage exclusion in long‐standing persistent atrial fibrillation

    by Adnan Ahmed, Rachad Ghazal, Danish Bawa, Douglas Darden, Scott Koerber, Rishit Chilappa, Rajesh Kabra, Justin Van Meeteren, Ahmed Romeya, Rakesh Gopinathannair, et al.

    Introduction: Management of patients with long‐standing persistent atrial fibrillation (LSPAF) presents a clinical challenge. Hybrid convergent ablation has been shown to have superior efficacy compared to endocardial‐only ablation. However, data on concomitant left atrial appendage (LAA) management along with hybrid ablation is sparse.Methods: We aimed to evaluate the effectiveness of concomitant hybrid convergent ablation and LAA clipping in patients with LSPAF. We conducted a retrospective analysis of all patients with LSPAF who underwent hybrid surgical ablation with LAA clipping at our institution. The primary endpoint was a recurrence of atrial arrhythmias at 12 months. Further, the durability of surgical left atrial posterior wall ablation was examined during the endocardial catheter ablation using standing electrophysiological criteria.Results: A total of 79 patients were included. Mean age was 63.5 ± 9.6 years, and 71% were males. LAA clipping was performed in 99% of patients. The mean time between the surgical and endocardial stages of the procedure was 2.6 ± 1.7 months. Persistent posterior wall activity was observed in 34.2% (n = 27/79) patients during the endocardial phase of the procedure. Cardiac implantable electronic device was used in 74% of patients for monitoring of recurrence of atrial fibrillation (AF). The primary effectiveness of AF freedom at 12 months was 73.8% (45/61). Over a 12‐month follow‐up period, 11.4% (9/79) of patients required repeat catheter ablation, of which 88.9% (8/9) had evidence of persistent posterior wall activity.Conclusion: Concomitant hybrid convergent ablation and LAA exclusion with an atrial clip provides reasonable long‐term AF‐free survival in patients with LSPAF. Persistent posterior wall activity is seen commonly in patients presenting with recurrent AF following hybrid convergent AF ablation.


  • Electrical delays in quadripolar leads with cardiac resynchronization therapy

    by Scott M. Koerber, Michael E. Field, Daniel B. Cobb, Mathew J. Gregoski, John L. Sturdivant, Michael R. Gold

    Background: Pacing at sites of late intraventricular activation (QLV) or long interventricular conduction (right ventricle [RV]‐left ventricular [LV]) have been associated with improved cardiac resynchronization therapy (CRT) outcomes. Quadripolar leads improve CRT outcomes by allowing for electrical repositioning to optimize pacing sites. However, little is known regarding the effect of such repositioning on electrical delay.Objective: Determine the relationship between different electrical bipoles from a quadripolar lead and measures of electrical delay.Methods: Forty‐six patients underwent CRT with a quadripolar lead. The RV‐LV and QLV intervals were measured for both the proximal and distal bipoles and the difference (Δ) between bipoles for each measure were calculated. Multivariate analyses were performed to identify predictors of electrical delays.Results: This was a typical CRT population with a mean age of 65 years and ejection fraction of 27%, with left bundle branch block (LBBB) present in 70%. The regression model for ΔQLV was significant (p = .05), with both gender (p = .008) and LBBB status (p = .020) significant predictors. The overall regression model for ΔRV‐LV was not significant. ΔQLV and ΔRV‐LV were significant among LBBB patients. Among non‐LBBB, only ΔRV‐LV was significant (mean: 7.2 ms, p = .006). ΔRV‐LV versus ΔQLV were strongly correlated in LBBB (R2 = .92) but not non‐LBBB (R2 = .06).Conclusion: In LBBB, ΔRV‐LV and ΔQLV are closely correlated suggesting that the proximal bipole and thus basal LV pacing sites should be selected when feasible. Greater variation in activation pattern is present in non‐LBBB, so pacing sites should be individualized.


  • Letter to Editor Response

    by Scott M. Koerber, Michael R. Gold

  • Prophylactic pulmonary vein isolation during cavotricuspid isthmus ablation for atrial flutter: A meta‐analysis

    by Scott M. Koerber, Mohit K. Turagam, Sandeep Gautam, Jeffrey Winterfield, J. Marcus Wharton, Dhanunjaya Lakkireddy, Michael R. Gold

    Background: Atrial arrhythmias (AA), including atrial fibrillation (AF), have been reported in patients after cavotricuspid isthmus (CTI) ablation for typical atrial flutter (AFL). Several studies have examined the effect of performing concomitant pulmonary vein isolation (PVI) with CTI on recurrent AA. These studies were analyzed to determine the overall effect of this approach on recurrent AA.Methods: PubMed and Google Scholar were searched for randomized trials comparing the incidence of AA after CTI versus CTI + PVI until June 2018. Only patients without prior history of AF were included in the recurrent AA analysis. All patients were included in the analyses of other clinical outcomes.Results: Four randomized control trials were included in the meta‐analysis. In the recurrent AA analysis, a total of 314 patients were randomized in the studies (n = 158 CTI, n = 156 CTI + PVI). Freedom from AA at 1 year was significantly higher in the CTI + PVI group versus CTI alone (odds ratio [OR] 0.25 [0.14, 0.44] 95% confidence interval [CI], P < 0.00001). A total of 550 patients (n = 336 CTI, n = 214 CTI + PVI) were included in analyses for procedure time, fluoroscopy time, and complications rates. Procedure time and fluoroscopy time were significantly longer in the CTI + PVI group (mean difference [MD]: 103.31 min [94.40, 112.23] 95% CI, P < 0.00001) and (MD: 16.47 min [14.89, 18.05] 95% CI, P < 0.00001), respectively. Total complications were statistically similar between groups.Conclusion: This meta‐analysis shows addition of a prophylactic PVI during CTI ablation significantly reduces recurrent AA at 1 year without significantly increasing major complications.


  • Percutaneous ventricular assist device in ventricular tachycardia ablation: a systematic review and meta-analysis

    by Mohit K. Turagam, Venkat Vuddanda, Scott Koerber, Jalaj Garg, Bharath Yarlagadda, Tawseef Dar, Arash Aryana, Luigi Di Biase, Andrea Natale, Dhanunjaya Lakkireddy

    There is a lack of compelling data regarding the benefit of percutaneous ventricular assist devices (PVAD) in patients undergoing ventricular tachycardia (VT) ablation. The study aims to conduct a meta-analysis comparing the safety and efficacy of PVAD versus no-PVAD (N-PVAD) during VT ablation.


  • Noninvasive tissue adhesive for cardiac implantable electronic device pocket closure: the TAPE pilot study

    by S. M. Koerber, T. Loethen, M. Turagam, J. Payne, R. Weachter, G. Flaker, M. R. Gold, S. Gautam

    Device infection is a serious complication of cardiac implantable electronic devices (CIED). Ensuring complete pocket closure can be time consuming, but remains vital to prevent infection. The Zip® Surgical Skin Closure (ZIP) is a noninvasive adhesive device applied to the skin as an alternative to subcuticular sutures for skin closure. We hypothesized that using this device would decrease pocket closure times without increasing the risk of pocket infections. This is a single center, retrospective cohort study to compare pocket closure times and infection rates between ZIP and standard suture for CIED pocket closure.


  • Abstract 21017: A Systematic Review and Meta-Analysis on Success and Complications of Epicardial Access

    by Mohit K Turagam, Scott Koerber, Venkat Vuddanda, Sudarshan Balla, Donita Atkins, Luigi Di Biase, Andrea Natale, Dhanunjaya Lakkireddy

    Background: Epicardial access (EA) is increasingly used in various electrophysiological procedures with wide variation in EA success and complications. Methods: A comprehensive search was performed in PubMed, EBSCO and Google Scholar databases for studies reporting success and complications with EA. Meta-analysis was done using MedCalc software with random effects-model. Procedural success was defined as successful pericardial access. Pericardial tamponade was defined as pericardial effusion requiring drainage. Success and complications were adjusted and calculated per 100 procedures. Results: A total of 6 studies [retrospective - 5, prospective - 1] including 1,122 patients [large bore (LB) - 878, micropuncture (MP) - 219 and EpiAcces- 25 patients] undergoing EA for ventricular tachycardia ablation and Lariat procedure. Table 1,2 demonstrates rates of procedural success and complications of EA. Acute procedural success was 94.9% [95% CI (93.1 - 96.1)]. Pericardial tamponade, pericardial effusion, emergency heart surgery and RV puncture were seen in 1.7%, 2.8%, 0.7% and 6.5% respectively. Conclusion: EA is feasible with a 95% procedural success and acceptable rate of major complications. Use of MP needle and advancement in other EA technology will further improve procedure safety.